Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P194. Is there a difference in quality of life or costs between ulcerative colitis patients with a pouch or an ileostomy?
P194. Methylene Blue orally administered tablets (MB MMX®) is effective in detecting intraepithelial dysplasia in patients with long standing ulcerative colitis
Authors:

S. Danese1, G. Fiorino1, A. Repici2, 1IRCSS Humanitas, IBD Center, Rozzano, Italy, 2IRCCS Humanitas, Gastroenterology and Digestive Endoscopy, Rozzano, Italy

P194

The Assessment of Disease Activity by Quantitative Fecal Immunochemical Test in Ulcerative Colitis

Authors:

H.W. Kim, S.B. Park*, C.W. Choi, D.H. Kang, G.A. Song

Pusan National University Yangsan Hospital, Internal Medicine, Yangsan, South Korea

P195.

Leukocyte scintigraphy as a tool to measure inflammatory load in ulcerative colitis

Authors:

J.F. Brandse1, R. Bennink2, S. Van Eeden3, P.A. Baars4, M. Löwenberg1, C.Y. Ponsioen1, G.R. van den Brink1, G. D'Haens1, 1Academic Medical Center, Inflammatory Bowel Disease Centre, Amsterdam, Netherlands, 2Academic Medical Center, Nuclear Medicine, Amsterdam, Netherlands, 3Academic Medical Center, Pathology, Amsterdam, Netherlands, 4Academic Medical Center, Clinical Immunology, Amsterdam, Netherlands

P195. Endomicroscopy for assessing mucosal healing in patients with ulcerative colitis – a pilot study
P195. Mannose-binding lectin deficiency is not associated with anti-Saccharomyces cerevisiae antibody in Korean Crohn's disease patients
Authors:

Y.S. Kim1, Y.-H. Kim2, B.D. Ye3, J.W. Kim4, D.S. Han5, 1Inje University, Internal Medicine, Seoul, South Korea, 2Sungkyunkwan University School of Medicine, South Korea, 3University of Ulsan College of Medicine, South Korea, 4Seoul National University College of Medicine, South Korea, 5Hanyang University College of Medicine, South Korea

P195. Role of white cell apheresis in refractory ulcerative colitis: UK experience
P195

Bone metabolic disease in Inflammatory Bowel Disease patients with past or current corticosteroid treatment

Authors:

J. Miranda-Bautista*1, M.D. Perez-Valderas1, A. Caballero-Marcos2, A. Diaz-Redondo3, I. Marin-Jimenez1, L. Menchen1

1Hospital General Universitario "Gregorio Marañón", Gastroenterology Unit, Madrid, Spain, 2Hospital General Universitario , Gastroenterology Unit, Madrid, Spain, 3Hospital General Universitario , Preventive medicine and Epidemiology Service, Madrid, Spain

P196.

Laboratory assessment of inflammation activity in pediatric inflammatory bowel disease

Authors:

R. Shentova1, E. Panteleeva1, P. Yaneva1, M. Baycheva1, A. Michova2, C. Zhelev1, 1University Pediatric Hospital – Sofia, Gastroenterology and Hepatology, Sofia, Bulgaria, 2Military Medical Academy, Pathomorphology, autopsy and biopsy diagnosis, Sofia, Bulgaria

P196. Are the results of multicenter trials hampered by country variability? Comparison between two endpoints used in a study with interferon-β-1a in ulcerative colitis
P196. Magnetic resonance imaging of the hands and knees in inflammatory bowel disease patients with arthralgia
Authors:

L. Brakenhoff1, W. Stomp2, F. van Gaalen3, H. Fidder4, J. Bloem2, D. van der Heijde3, M. Reijnierse2, D. Hommes5, 1Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, Netherlands, 2Leiden University Medical Center, Radiology, Leiden, Netherlands, 3Leiden University Medical Center, Rheumatology, Leiden, Netherlands, 4University Medical Center Utrecht, Gastroenterology and Hepatology, Utrecht, Netherlands, 5University of California Los Angeles, Center for Inflammatory Bowel Diseases, Los Angeles, United States

P196. p53, COX‑2 and BCL‑2 in patients with ulcerative colitis with or without coexistence of the primary sclerosing cholangitis and after liver transplantation – immunohistochemical study
P196

Fatigue Severity and Factors Associated with High Fatigue Levels in Tunisian Patients with Inflammatory Bowel Disease

Authors:

N. Ben Mustapha*, M. Mahmoudi, M. Bejaoui, A. Laabidi, L. Kallel, M. Serghini, M. Fekih, S. Matri, J. Boubaker, A. Filali

La Rabta Hospital, Gastroenterology A, Tunis, Tunisia

P197.

Is the tuberculin skin test alone accurate in moderate-to-severe BCG vaccinated patients with inflammatory bowel disease to test for latent tuberculosis?

Authors:

P.A. Golovics1, A. Szabo1, M. Mandel1, A. Gyurcsanyi1, K. Kristof2, Z. Vegh1, A. Mohas1, B. Szilagyi1, Z. Kurti1, B. Csako1, L. Kiss1, B. Lovasz1, K. Gecse1, P. Lakatos1, 1Semmelweis University, 1st Department of Medicine, Budapest, Hungary, 2Semmelweis University, Institute of Medical Microbiology, Budapest, Hungary

P197. Application of the WHO Fracture Risk Assessment Tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis
P197. Magnetic resonance enterography for the assessment of Crohn's disease: changing imaging paradigms?
Authors:

K.L. White1, S. Soteriadou1, K. McWhirter1, R. Filobbos2, J.K. Limdi1, 1Pennine Acute Hospitals, Gastroenterology, Manchester, United Kingdom, 2Pennine Acute Hospitals, Radiology, Manchester, United Kingdom

P197. Predictors of clinical remission in ulcerative colitis patients treated with anti‑TNF: Results from a prospective study
P197

Retrospective Analysis of Enterocutaneous Fistula Management in IBD

Authors:

M. Boyle*, G. Doherty, G. Cullen

St Vincents University Hospital, Gastroenterology, Dublin, Ireland

P198.

Is terminal ileal inflammation predictive of small bowel Crohn's disease?

Authors:

B. Hall1,2, G. Holleran1,2, V. Parihar2, D. McNamara1,2, 1Trinity College Dublin, Department of Clinical Medicine, Dublin, Ireland, 2Adelaide and Meath Hospital, Department of Gastroenterology, Dublin, Ireland

P198. Assessing relationships between compliance and clinical recurrence in patients with quiescent ulcerative colitis receiving MMX® mesalazine 2.4 g/day as maintenance therapy: The phase IV SIMPLE trial